Viewing Study NCT01541644



Ignite Creation Date: 2024-05-06 @ 12:19 AM
Last Modification Date: 2024-10-26 @ 10:47 AM
Study NCT ID: NCT01541644
Status: COMPLETED
Last Update Posted: 2019-11-07
First Post: 2012-02-20

Brief Title: 1068GCC Evaluate Efficacy Explore Mechanism of Acupuncture in Treating Bortezomib-induced Peripheral Neuropathy BIPN in Multiple Myeloma
Sponsor: University of Maryland Baltimore
Organization: University of Maryland Baltimore

Study Overview

Official Title: A Pilot Study to Evaluate the Efficacy and Explore the Mechanism of Acupuncture in Treating Bortezomib-induced Peripheral Neuropathy BIPN in Multiple Myeloma Patients
Status: COMPLETED
Status Verified Date: 2019-11
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Patients are asked to be in this study if they have multiple myeloma and are having tingling numbness and pain from taking bortezomib velcade Patients who have been diagnosed with multiple myeloma often take bortezomib velcade

This research is being done to find out if acupuncture can reduce the nerve pain tingling andor numbness patients experience due to bortezomib velcade

Acupuncture is a medical technique of inserting very thin needles into the energy points on the body with the aim to restore health and well-being It has been used widely to treat pain such as lower back pain and nerve pain In this study we will see if acupuncture can be used to ease nerve pain and tingling numbness that is caused by bortezomib
Detailed Description: Information gained from this clinical trial will provide insight into the efficacy and mechanism of acupuncture in reducing Bortezomib-induced Peripheral Neuropathy BIPN in multiple myeloma patients It will examine the effect of acupuncture on serum proinflammatory cytokine and β-endorphin levels to further understand the mechanism of acupuncture on a molecular level This study is the first clinical trial studying the effect of acupuncture on treating BIPN It is also the first study to explore the mechanism of acupuncture through frequent small amount of blood draws at six time points to detect changes in proinflammatory cytokines and β-endorphins It has the potential to identify a minimal risk non-pharmacological intervention to alleviate BIPN symptoms and to significantly improve our understanding of the mechanism of acupuncture

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
GCC 1068 OTHER University of Maryland Greenebaum Cancer Center None